Clinical Trial Update: The Blood Pressure and Metabolic Effects of Nebivolol in Hypertensive Patients With Impaired Glucose Tolerance or Impaired Fasting Glucose [Phase 4]

View source ↗

Summary

Phase 4 trial update on the blood pressure and metabolic effects of nebivolol in hypertensive patients with impaired glucose tolerance or impaired fasting gluco…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertension
• Impaired Fasting Glucose
• Impaired Glucose Tolerance

Drugs mentioned

• Nebivolol (Nebivolol)

Snippet

Sponsor: Forest Laboratories | Conditions: Hypertension | Phase 4 | Status: COMPLETED | Results posted: 2020-02-26